ADC Therapeutics SA (ADCT) KPIs and segments
Close on Nov 13, 2026Market cap $171.08MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive ADC Therapeutics's business
ADC Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product revenues, net($M) | 18.6 | 20.0 | 22.3 | 15.8 | 18.1 | 17.4 | 16.4 | 18.0 | 17.0 | 17.8 | 16.6 | 14.3 | |
Royalties($M) | 0.61 | 0.82 | 0.75 | 0.68 | 0.75 | 0.63 | 0.52 | 0.45 | 0.38 | 0.21 | 0.15 | 0.23 | |
License revenues($M) | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | |||
License revenues and royalties($M) | 0 | ||||||||||||
United States($M) | 18.6 | 20.0 | 22.3 | 15.8 | 18.1 | 17.4 | 16.4 | 18.0 | 17.0 | 17.8 | 16.6 | 14.3 | |
EMEA($M) | 0.61 | 0.82 | 0.75 | 0.68 | 0.75 | 5.63 | 0.52 | 0.45 | 0.38 | 0.21 | 0.15 | 0.23 | |
Earlier reporting (last reported 2023)1 | |||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?